A Parent Administered Sensorimotor Intervention & Developmental Outcome of

Status Completed

Clinical Trial Summary

Advances in medical technologies over the last three decades have increased survival rates in infants born preterm . Preterm infants are at high risk of developing developmental delays. Implementation of effective strategies aimed at improving the developmental outcome of preterm born children is critical. The proposed study is designed to evaluate the addition of a parent administered sensorimotor program on the developmental outcome of infants who are born preterm.

Clinical Trial Description

Children who are born prematurely are at a higher risk of developing developmental delays than children born at term. Early experiences in the neonatal intensive care unit (NICU) can influence developmental outcomes. Sensorimotor interventions as well as parental engagement have been designed with the aim of improving the development of children born preterm. Substantial evidence supports the benefits of each intervention on improving developmental outcomes. However, there remains a significant gap in the literature on the efficacy of a parent administered sensorimotor intervention (PASI) program in the NICU on infant's development. The proposed study is designed to evaluate the potential benefits of such a program on infant's development. A randomized block clinical trial will be performed. A total of 84 preterm infants (< 34 weeks gestation) will be recruited and randomized. Infants in the experimental group will receive the sensorimotor program,consisting of tactile (whole body) and oral input for 15 minutes, one time per day, for 10 days. Infants in the control group will receive standard care. The following outcomes will be monitored time to attainment of complete oral feeds (primary outcome), rate of weight gain, length of hospitalization, and developmental outcomes at 36 weeks corrected gestational age and at 4, 8, 12, 18 and 24 months corrected age. Results from this study will provide us with further knowledge on the impact of sensorimotor intervention on infants' developmental outcome as well as the effect of active parental involvement on infants' development. Provision of a PASI program is a safe and low cost effective intervention that may increase the development and quality of life of preterm born children and their family. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03836326
Study type	Interventional
Source	Queen's University
Contact
Status	Completed
Phase	N/A
Start date	July 1, 2019
Completion date	May 1, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT06052410` - Early Intervention in Children at Risk of Developmental Delay	N/A
Not yet recruiting	`NCT06458959` - Exploratory Trial of a Pediatric Web-Based Care Planning Guide	N/A
Recruiting	`NCT04518332` - Intraoperative Cerebral and Renal Tissue Oxygen Saturation and Pediatric Living Donor Liver Transplantation Prognosis.
Active, not recruiting	`NCT02000284` - Mitochondrial Dysfunction in Autism Spectrum Disorder
Recruiting	`NCT05527080` - Development of Motility and Cognition in Infants
Recruiting	`NCT04672967` - MAP Autism Prediction Study
Completed	`NCT02712853` - Improving Autism Screening With Brain-Related miRNA
Completed	`NCT01975506` - Occupational Therapy in the Context of Head Start	N/A
Completed	`NCT01253083` - Mobility Training to Improve Motor Behavior in Toddlers With or at Risk for Cerebral Palsy: A Pilot Study	Phase 1
Not yet recruiting	`NCT05605977` - Home-based Visual-motor Training Program on Kindergarteners	N/A
Completed	`NCT05408351` - The Indonesian Version of Ages and Stages Questionnaire III Accuracy Compared to Bayley Scales of Infant Development III
Completed	`NCT02832557` - A Salivary miRNA Diagnostic Test for Autism
Recruiting	`NCT02769949` - Pediatric Patients With Metabolic or Other Genetic Disorders
Active, not recruiting	`NCT02813889` - SmarToyGym: Smart Detection of Atypical Toy-oriented Actions in At-risk Infants	N/A
Completed	`NCT02115334` - Development and Effectiveness of Home-based Programs for Preschool Children With Developmental Delay	N/A
Completed	`NCT01351077` - CHICA Developmental Screening Study	N/A
Recruiting	`NCT06461572` - Effects of Power Ball on Proximal Muscle and Refractive Errors in Developmental Delay.	N/A
Suspended	`NCT03307317` - Mirror Neuron Network Dysfunction as an Early Biomarker of Neurodevelopmental Disorder
Completed	`NCT03223688` - Early Intervention for Developmental Delay	N/A
Completed	`NCT02141802` - Clinical Effectiveness of Increased Standing Time in Non-ambulant Children With Cerebral Palsy:a Pilot Study	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

A Parent Administered Sensorimotor Intervention and Developmental Outcome of Preterm Infants

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms